AMH Concentrations in Peritoneal Fluids of Women With and Without Endometriosis
Authors:
Open Access
- 11 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 7
Abstract
Background: As its name indicates, anti-Müllerian hormone (AMH) is primarily found as an inhibitor of the Müllerian duct in male fetus. On the other hand, AMH may act as a mediator of Müllerian duct-derived female tissue, such as endometrium in normal and pathological conditions. However, the role of AMH in the functional regulations of endometriosis is not well understood. It can be hypothesized that AMH in peritoneal fluids may affect the activity of peritoneal endometriosis. In this study, we investigated the levels of AMH in peritoneal fluids (PF) in women with and without endometriosis. Methods: PF were collected during laparoscopy from 90 women diagnosed as having advanced endometriosis (rASRM stage III, n = 30; stage IV, n = 60), and 32 women without endometriosis were served as control. Paired serum samples were also collected before the surgery. AMH in PF and serum were measured by ELISA. Individual clinical information was collected. AMH levels were compared according to the presence of endometriosis. The expression of AMHR2 in peritoneal endometriotic lesions obtained during laparoscopy was examined by immunohistochemistry. Results: AMH levels in PF were positively and significantly correlated with serum AMH levels in both women with and without endometriosis (R2 = 0.17, P < 0.0001; R2 = 0.30, P = 0.001, respectively). Serum AMH levels were inversely and significantly correlated with age in women with endometriosis (R2 = 0.092, P = 0.004) and in control women without statistical significance (R2 = 0.078, P = 0.12). AMH levels in PF were also inversely but not significantly correlated with age in women with and without endometriosis (R2 = 0.029, P = 0.11 and R2 = 0.027, P = 0.37, respectively). Mean age and serum AMH levels were not significantly different between two groups. On the other hand, AMH levels in PF were significantly lower in women with endometriosis compared to those of control women [2.15 ± 2.13 (mean ± SD) vs. 4.40 ± 4.77 ng/mL, P = 0.0001]. AMHR2 are localized at glandular epithelium and stromal cells in the ectopic endometrium of peritoneal endometriosis. Conclusions: Women with endometriosis may present lower PF AMH levels even if they retain serum levels similar to women without disease. As peritoneal endometriosis expresses a specific receptor for AMH, lower AMH levels in PF of women with advanced endometriosis may be involved in the pathophysiology of peritoneal endometriosis.Keywords
This publication has 18 references indexed in Scilit:
- Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cellsJournal of Experimental & Clinical Cancer Research, 2014
- Increased expression of antimüllerian hormone and its receptor in endometriosisFertility and Sterility, 2014
- Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomasFertility and Sterility, 2014
- The physiology and clinical utility of anti-Müllerian hormone in womenHuman Reproduction Update, 2014
- Müllerian Inhibiting Substance Induces Apoptosis of Human Endometrial Stromal Cells in EndometriosisThe Journal of Clinical Endocrinology & Metabolism, 2012
- Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)Human Reproduction Update, 2009
- High prevalence of endometriosis in infertile women with normal ovulation and normospermic partnersFertility and Sterility, 2009
- Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometriumFertility and Sterility, 2009
- Anti-Müllerian hormone and folliculogenesisMolecular and Cellular Endocrinology, 2005
- Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting SubstanceProceedings of the National Academy of Sciences, 2004